ROCKVILLE, Md., Oct. 5, 2006 (PRIMEZONE) -- Cytomedix, Inc. (AMEX:GTF) today announced an update on the 510(k) Premarket Notification needed for marketing clearance for the AutoloGel(tm) System that has been filed with the U.S. Food and Drug Administration (FDA).